Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Plos Pathogens|November 18, 2024
Polyamines mediate cellular energetics and lipid metabolism through mitochondrial respiration to facilitate virus replicationYazmin E Cruz-Pulido, Natalie J LoMascolo, Delaina May, et al.Disease Models & Mechanisms|May 10, 2017
Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routesGabriella Passoni, Christelle Langevin, Nuno Palha, et al.Plos Neglected Tropical Diseases|January 26, 2016
Whole-Genome Sequencing Analysis from the Chikungunya Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic ElementsKenneth A Stapleford, Gonzalo Moratorio, Rasmus Henningsson, et al.Cell Death & Disease|October 28, 2016
ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.Cell Death & Disease|November 22, 2018
Correction to: ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephalyVincent El Ghouzzi, Federico T Bianchi, Ivan Molineris, et al.Journal of Virology|August 19, 2016
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA VirusesBryan C Mounce, Teresa Cesaro, Gonzalo Moratorio, et al.Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitroNir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.Pageof 5